GUTS Profile
Fractyl Health, Inc., a leading metabolic therapeutics company, focuses on developing innovative therapies for the treatment of type 2 diabetes (T2D) and obesity. The company is at the forefront of metabolic health, aiming to address the root causes of these prevalent diseases. One of its primary products is the Revita DMR System (Revita), an outpatient procedural therapy designed to modify duodenal dysfunction. This dysfunction, often a result of a high-fat and high-sugar diet, is a significant contributor to the onset of T2D and obesity in humans. Revita's therapeutic approach seeks to provide a durable solution to these conditions by targeting the underlying metabolic pathways.
In addition to Revita, Fractyl Health is developing Rejuva, a groundbreaking virus-delivered pancreatic gene therapy platform. Rejuva aims to enable long-term remission of T2D and obesity by altering metabolic hormone function in the pancreatic islet cells of patients. This novel approach holds the promise of providing a sustainable solution to these chronic conditions, moving beyond traditional management strategies to potentially curative therapies. The company's commitment to innovative science and patient-centered care drives its research and development efforts.
Fractyl Health, Inc. was originally founded as Fractyl Laboratories Inc. and underwent a rebranding to its current name on June 09, 2021, to better reflect its mission and scope. The company's strategic focus on metabolic therapeutics positions it as a key player in the healthcare industry, with the potential to significantly impact the treatment landscape for T2D and obesity. Through its pioneering therapies, Fractyl Health aims to improve the quality of life for millions of patients worldwide who are affected by these metabolic diseases.
Founded in 2010 and headquartered in Lexington, Massachusetts, Fractyl Health continues to expand its research and clinical development capabilities. The company collaborates with leading academic and medical institutions to advance its therapeutic platforms and bring new treatments to market. With a dedicated team of scientists, clinicians, and industry experts, Fractyl Health is well-positioned to lead the way in transforming the management and treatment of metabolic diseases, offering hope for lasting remission and improved patient outcomes.
|
